Free shipping on all orders over $ 500

 About 1 result found for searched term "1129403-56-0" (0.123 seconds)

Cat.No.  Name Target
M20626 Amcasertib (BBI503) Others
Amcasertib (BBI-503) is an oral first-in-class cancer stemness kinase inhibitor. By targeting multiple serine-threonine stemness kinases, amcasertib inhibits Nanog and other cancer stemness pathways.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.